Companies: 49,246 Total Market Cap: 132386205533959.40

Memphis Pharmaceuticals & Chemical Industries

EGX-MPCI
Pharmaceutical Preparations
Rank #31945
Market Cap 34.08 M
Volume 27,542
Price 1.51
Change (%) 0.91%
Country or region Egypt Egypt

Memphis Pharmaceuticals & Chemical Industries's latest marketcap:

34.08 M

As of 05/20/2025, Memphis Pharmaceuticals & Chemical Industries's market capitalization has reached $34.08 M. According to our data, Memphis Pharmaceuticals & Chemical Industries is the 31945th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 34.08 M
Revenue (ttm) 24.03 M
Net Income (ttm) 7.36 M
Shares Out 22.75 M
EPS (ttm) 1.31
Forward PE 0.00
Ex-Dividend Date 11/13/2024
Earnings Date 05/14/2025
Market Cap Chart
Data Updated: 05/20/2025

Memphis Pharmaceuticals & Chemical Industries's yearly market capitalization.

Memphis Pharmaceuticals & Chemical Industries has seen its market value grow from 107.44 M EGP to 1.74 B EGP since 2020, representing a total increase of 1,523.28% and an annual compound growth rate (CAGR) of 88.80%.
Date Market Cap(EGP) Change (%)
05/20/2025 1.74 B 504.96%
12/31/2024 293.29 M -16.86%
12/31/2023 352.74 M 252.3%
12/29/2022 100.13 M -15.24%
12/30/2021 118.13 M 9.95%
12/31/2020 107.44 M

Company Profile

About Memphis Pharmaceuticals & Chemical Industries

Memphis Pharmaceuticals & Chemical Industries is a leading drug holding company specializing in the production and distribution of pharmaceutical products for both human and veterinary use. Operating primarily in Egypt with an international presence, the company has been a trusted name in the industry since its founding in 1940.

Human Health Products

The company offers a diverse range of human health products across multiple therapeutic areas, including:

  • Anti-infective
  • CNS (Central Nervous System)
  • Dermatological
  • Cardiovascular system
  • Corticosteroid
  • Vitamins and minerals
  • Musculo-skeletal system
  • Analgesic and antipyretic
  • Respiratory system
  • Genitourinary system
  • Alimentary tract and metabolism
  • Antihistaminic
  • Antiparasites
  • Hormones

Animal Health Products

In addition to human pharmaceuticals, Memphis Pharmaceuticals provides veterinary solutions in various forms, such as:

  • Powder formulations
  • Oral solutions
  • Injectable solutions

Headquarters: Cairo, Egypt
Parent Company: HoldiPharma

Frequently Asked Questions

As of 05/20/2025, Memphis Pharmaceuticals & Chemical Industries (including the parent company, if applicable) has an estimated market capitalization of $34.08 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Memphis Pharmaceuticals & Chemical Industries global market capitalization ranking is approximately 31945 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Egypt
Founded 1940
IPO Date n/a
Employees 144
CEO Bassem Abdullah
Sector
Industry Pharmaceutical Preparations
Address 8 El Sawah - Amireya
Cairo, 11281
Egypt
Website https://www.memphis.com.eg
People Also Watch
Ipsen S.A.
138.21 0.91%
Krka, d. d.
209.75 0.91%
BUD-RICHTER
29.11 0.91%
Hugel
244.93 0.91%